- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
- Industry news
- Financial Results
News of the day
Dragon Achieved Solid Increase in Sales and Profits from Continuing Operations for Q3
November 14, 2008--Dragon Pharmaceutical Inc. (TSX: DDD; OTC BB: DRUG; BBSE: DRP) today announced its financial results for the three and nine months ended September 30, 2007, showing strong growth in sales and profits for its core antibiotic business. Meanwhile, the Company also announced the sale of its EPO operation to an unaffiliated party through a separate press release. moreSORIN GROUP ANNOUNCES H1 2008 RESULTS: NET EARNINGS AT 14.4 MILLION EUROS AND NET DEBT DOWN TO 270.3 MILLION EUROS AS OF JUNE 30, 2008.
Milan, August 26, 2008 - The Board of Directors of Sorin S.p.A. in a meeting today chaired by Umberto Rosa, approved the Financial Statements for the 1st half of 2008, which closed on June 30, confirming the preliminary figures for Q2 08 which had already been announced on July 25, 2008. moreALK-Abell
H moreIndustry news search
Most Viewed News
- Dragon Achieved Solid Increase in Sales and Profits from Continuing Operations for Q3
- PROMETIC REPORTS BUSINESS HIGHLIGHTS AND SECOND QUARTER FINANCIAL RESULTS
- UCB reports financials in line with expectations, integration completed, R&D milestones achieved and stronger focus on core business
- Analogic Corporation Completes Fourth Quarter Restructuring Initiatives, Provides Update on Recent Acquisition, and Announces Fourth Quarter Investor Conference Call
- ELRON ELECTRONIC INDUSTRIES ANNOUNCES SECOND QUARTER 2008 RESULTS
- RSS Feed...
Recent news
To keep up to date with news from this category use our
Deltagen Reports 2008 Second Quarter Financial Results
SAN MATEO, California, August 26, 2008 - Deltagen, Inc. (Pink Sheets: DGEN), a leading provider of drug discovery tools to the biopharmaceutical industry, today reported unaudited consolidated financial results for the...
Biofrontera AG reports first half financial results for 2008
Leverkusen, Germany -August 26, 2008-- Biofrontera AG (DSE: B8F) today presents financial results for the first half of 2008. The semiannual report, which is being published today on the company's website, deals in...
Mindray Releases Historical Financial Results Converted into US Dollar Terms
SHENZHEN, China August 25, 2008 -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China, today released select historical financial figures...
2008 Preliminary Final Report and Annual Report
Melbourne, Australia -- 25 August 2008 - Biota Holdings Limited (ASX:BTA) today announced a full year loss after tax of $6.5 million (2007: profit $20.2m). The loss before tax was $9.3 million and the tax credit was...
2008 Annual Results
Melbourne, Australia -- 25 August 2008 Biota Holdings Limited (ASX:BTA) today announced a full year loss after tax of $6.5 million (2007: profit $20.2m). The loss before tax was $9.3 million and the tax credit was $2.8...
Northfield Laboratories Inc. Reports Fiscal 2008 Fourth Quarter and Year-End Financial Results Reminder to Shareholders
EVANSTON, Ill.-- August 22, 2008--Northfield Laboratories Inc. (Nasdaq: NFLD) provided this reminder to shareholders: the Company filed its Annual Report on Form 10K, letter from the Chairman, and final Proxy Statement...
Santhera's 2008 Interim Results Reflect Advances in Clinical Development and Preparation for First Product Launch
August 22, 2008, Santhera will host a conference call webcasted on www.santhera.com/webcasts. Anyone interested in participating may join the conference using the dial-in +41 (0)44 580 73 80.
Alchemia Announces solid progress over the past 12 months
August 22, 2008 --BRISBANE, AUSTRALIA: Alchemia Limited (ASX:ACL) today announced its audited financial results for the full year to 30 June 2008. Alchemia has made substantial progress with its generic fondaparinux,...
BIONOMICS' 2007/2008 PRELIMINARY FINAL RESULTS.
August 22, 2008--Bionomics Limited (ASX: BNO) today announced its preliminary financial results for the year ended 30 June 2008.
Duska Therapeutics Provides Clinical Program Review and Reports Second Quarter 2008 Financial Results
LA JOLLA, Calif., Aug. 21 -- Duska Therapeutics, Inc. (OTC Bulletin Board: DSKA - News; "Duska") announced today a clinical review and its financial results for the second quarter of 2008.
Orient Europharma announces H1 report-EPS rises to NT$2.17 at a YoY increase of 68%-fla
August 21, 2008-The board of directors of Orient Europharma Co., Ltd. (OEP, stock code 4120) approved the company's financial report for the first half of 2008. Even though the global economy took a hit in the first...
MediCult Reports 2nd Quarter 2008 Results
Jyllinge, Denmark, August 21, 2008 -- MediCult a/s (OSE: MEC), a leader in Assisted Reproductive Technologies (ART), announced today results for the 2nd quarter ending 30th June 2008. During the quarter, MediCult...
CYBERONICS REPORTS STRONG REVENUE GROWTH AND PROFITABILITY IN FISCAL 2009 FIRST QUARTER
HOUSTON, Texas, August 21, 2008 -- Cyberonics, Inc. (NASDAQ:CYBX) today announced results for the quarter ended July 25, 2008.
Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
EXTON, Pa., August 21, 2008 -- Kensey Nash Corporation (Nasdaq: KNSY) today reported the results for its fourth quarter and fiscal year ended June 30, 2008.
Interim financial report, Q3 2007/08
Interim financial report, Q3 2007/08 Humleb
ARPIDA REPORTS INTERIM RESULTS FOR SIX MONTHS TO 30 JUNE 2008
Reinach, Switzerland, 20 August 2008. Arpida Ltd (SWX: ARPN) announced today its financial results for the six months ending 30 June 2008. Highlights 2008 to date Major pipeline progress:
NorDiag Q2-2008: Prototype of new cancer test completed
20 August 2008: NorDiag states today in its quarterly report that the prototype for its new test for colorectal cancer has been completed. `This is a major step towards market introduction of Genefec III,` says CEO M
IsoRay Inc. Announces Fourth Quarter & Fiscal Year 2008 Results
Richland, Washington (August 20, 2008) ... IsoRay Inc. (AMEX:ISR), a medical isotope company focused on the treatment of prostate cancer and other malignant disease through use of its proprietary radioisotope...
BioGaia AB Interim report 1 January - 30 June 2008
August 20, 2008--BioGaia AB Interim report 1 January - 30 June 2008
Candela Reports Fourth Quarter and Fiscal Year 2008 Results
WAYLAND, Mass.--Aug. 20, 2008--Candela Corporation (NASDAQ:CLZR) today reported results for the fourth fiscal quarter and fiscal year ended June 28, 2008. Revenues of $37.8 million in the fourth quarter decreased 3.1...
Clearant, Inc. Reports Record 2nd Quarter 2008 Revenue Results
LOS ANGELES, CA--Aug 20, 2008 -- Clearant, Inc. (OTC BB:CLRA.OB - News), owner of the Clearant Process
HP Reports Third Quarter 2008 Results
PALO ALTO, Calif.--Aug. 19, 2008--HP (NYSE:HPQ) today announced financial results for its third fiscal quarter ended July 31, 2008, with net revenue of $28.0 billion, up 10% from a year earlier and up 5% when adjusted...
Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
SUNNYVALE, Calif., August 19, 2008 - Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the fourth quarter and fiscal year ended June 28, 2008.
Myriad Genetics Reports Financial Results for Fiscal 2008
SALT LAKE CITY, UT, August 19, 2008 -- Myriad Genetics, Inc. (NASDAQ: MYGN) today reported financial results for its fourth quarter and fiscal year ended June 30, 2008.
Rosetta Genomics Reports Second Quarter 2008 Financial Results
REHOVOT, Israel and JERSEY CITY, New Jersey, August 19, 2008 -- Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based diagnostic and therapeutic products, reported today its consolidated financial...
Net profit increased by more than 50% Strategic and operational key projects well on track
August 19, 2008 -- Despite major challenges during the first half year the Galenica Group managed to present a very positive result: net sales climbed to CHF 1,338.7 million (+8.3%) leading to consolidated earnings...
Medtronic First Quarter Revenue Up 19 Percent to $3.706 Billion
MINNEAPOLIS - August 19, 2008 - Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2009, which ended July 25, 2008.
Trimedyne, Inc. (TMED) Reports a Net Loss for the Quarter Ended June 30, 2008
LAKE FOREST, CA--August 19, 2008 - TRIMEDYNE, INC. (OTCBB: TMED) today announced its financial results for the quarter and nine months ended June 30, 2008.
Strong Growth for QUMAS in 2008
Jersey City, NJ -- August 19, 2008 - QUMAS, a leading provider of regulatory compliance solutions to highly regulated companies, including Life Sciences and Financial Services organizations, today announced continued...
Open Text Reports Fourth Quarter and Fiscal Year-End 2008 Financial Results
Waterloo, ON - 2008-08-19 - Open Text(TM) Corporation (NASDAQ:OTEX) (TSX:OTC), a leading provider of Enterprise Content Management (ECM) software, today announced unaudited financial results for its fourth quarter and...
Bavarian Nordic A/S - Interim Report for the period 1 January to 30 June 2008
August 19, 2008--In the first half of 2008 Bavarian Nordic generated revenue of DKK 23 million and recorded a loss before tax of DKK 119 million. The expectations for the financial result for the full year 2008 are...
Celsion Corporation Reports Second Quarter 2008 Financial Results
COLUMBIA, Md., Aug 18, 2008 -- Celsion Corporation (NASDAQ: CLSN) today announced financial results for its second quarter ended June 30, 2008. The Company reported a net loss from continuing operations of $2.4 million,...
Affymax(R) Reports Second Quarter 2008 Financial Results
PALO ALTO, Calif., Aug 18, 2008 -- Affymax, Inc. (Nasdaq:AFFY) today reported financial results for the second quarter ended June 30, 2008. The net loss for the second quarter of 2008 was $18.9 million compared to a net...
Moving ahead - strong results in second quarter 2008
August 18, 2008 -- The financial results reported in this press release are related to Nycomed S.C.A. SICAR and comprise all of the Nycomed Group's operations. A full interim report is available at...
Interim Report for the Period January 1 to June 30, 2008 (Unaudited and Unreviewed)
August 18, 2008--Curalogic is currently negotiating with a limited number of companies each of which has a pipeline with potentially attractive clinical development projects. Common to these companies is that they...
MediVision Presents Management's Report for the period ended June 30, 2008
Yokneam Elit, Israel, MediVision Medical Imaging Ltd. ("MediVision", EURO.NM: MEDV) released today (August 18, 2008) information concerning its operations and financial results for the period ended June 30, 2008....
Intercell AG announces Q2/ H1 2008 results and gives update on business
Vienna (Austria), August 18, 2008 - Today Intercell AG (VSE: ICLL) announced the financial results for Q2 / H1 2008 and released an update on the company's developmental programs and strategy.
Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results
SEATTLE, Aug. 18 -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) reported financial results for the quarter ended June 30, 2008. Total revenues for the quarter were $2.9 million compared to $20,000 for the...
Photocure ASA - Second Quarter Report 2008
August 15th 2008-Hexvix sales revenue increased 108 % compared to the second quarter of 2007 The work being done to introduce Hexvix bladder cancer diagnostic in Europe by Photocure and GE Healthcare, Photocure s...
DOR BioPharma Reports 2nd Quarter 2008 Financial Results
Ewing, NJ - August 15, 2008 - DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company") today announced its financial results for the second quarter ended June 30, 2008.
Interim report January - June 2008
August 15, 2008--Net sales in the second quarter amounted to 121.3 MSEK (131.1) and to 235.3 MSEK (250.0) in the period January - June 2008. At comparable exchange rates net sales were unchanged in the second quarter...
Applied DNA Sciences Announces Increased Revenues for Third Quarter 2008 Company Provides Business Update
STONY BROOK, N.Y., August 15, 2008 -- Applied DNA Sciences, Inc. (OTC Bulletin Board: APDN) a provider of DNA-based security solutions reported its revenues for the third fiscal quarter of 2008 ending June 30, 2008....
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2009
KAILUA KONA, Hawaii (August 15, 2008) -- Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in producing high-value nutrition and health products from microalgae, today announced financial results for...
Bachem Group Half-Year Result 2008
Bubendorf, Switzerland, August 15, 2008 - Sales of the Bachem Group (SWX: BANB) reached CHF 98.7 million in the first six months of 2008 and thus lay 4.1% below the halfyear record sales of 2007 in CHF. In local...
Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
PRINCETON, N.J., Aug 14, 2008-- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, reported unaudited...
DERMA SCIENCES REPORTS SECOND QUARTER 2008 RESULTS
PRINCETON, NJ - (August 14, 2008)-- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced results today for the second quarter and first six months ended June 30, 2008....
Accentia Reports Fiscal Third Quarter Financial Results
August 14, 2008--Accentia Biopharmaceuticals, Inc., Tampa Douglas Calder, Director of Investor Relations & Public Relations, 813-864-2554, ext. 258 dwcalder@accentia.net Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI)...
Management's Discussion and Analysis of Financial Condition and Results of Operations
August 14, 2008-The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and...
Antares Pharma, Inc. (ANTR) Reports Second Quarter 2008 Financial Results
EWING, N.J.--August 14, 2008--Antares Pharma, Inc. (AMEX:AIS) today reported financial and operating results for the second quarter 2008. For the quarter ended June 30, 2008, the Company reported a net loss of $3.3...
Ivivi Technologies Reports First Quarter Fiscal 2009 Financial Results
MONTVALE, N.J., August 14, 2008 -- Ivivi Technologies, Inc. (Nasdaq:IVVI), a leader in non-invasive, electroceutical(r) therapy systems designed to target and enhance the body's anti-inflammatory response, today...
Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
SUNNYVALE, Calif., Aug 14, 2008-- Pharmacyclics, Inc. (Nasdaq: PCYC) today reported financial results for its fourth quarter and fiscal year ended June 30, 2008. The net loss for the fourth quarter of fiscal 2008 was...
DELSITE REPORTS SECOND QUARTER 2008 RESULTS
IRVING, TEXAS August 14, 2008 DelSite, Inc. (OTC: DSII.OB) today reported total revenue from continuing operations for the quarter ended June 30, 2008 of $2.0 million compared to revenue of $1.8 million in the year-ago...
Accentia Reports Fiscal Third Quarter Financial Results
TAMPA, Fla.--August 14, 2008--Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI - News) announced today that the Company has filed its Quarterly Report (Form 10-Q) with the SEC, reporting the results of its operations,...
ImaRx Therapeutics Reports Second Quarter Ended 2008 Financial Results
TUCSON, Ariz., August 14, 2008 -- ImaRx Therapeutics, Inc. (Nasdaq:IMRX), a biopharmaceutical company with a commercial product, urokinase, and a research and development program focused on the development of new...
Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
SOUTH EASTON, Mass., Aug. 14,2008 -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that total revenue for the second quarter of 2008 was $120,184 compared to $202,127 for the comparable period in the prior...
SPHERIX REPORTS 2nd QUARTER EARNINGS
BETHESDA, MD, August 14, 2008 - Spherix Incorporated (NASDAQ/SPEX) reported a net loss for the three and six months ended June 30, 2008 of $1.2 million ($0.08 per share) and $3.1 million ($0.22 per share). Research and...
Northfield Laboratories Inc. Reports Fiscal 2008 Fourth Quarter and Year-End Financial Results
EVANSTON, Ill -- August 14, 2008--Northfield Laboratories Inc. (Nasdaq: NFLD) announced today that it has filed its Annual Report on Form 10K, letter from the Chairman, and final Proxy Statement with the Securities...
Opexa Therapeutics Reports Second Quarter 2008 Financial Results and Recent Corporate Highlights
THE WOODLANDS, Texas--August 14, 2008--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing novel cell therapies for multiple sclerosis (MS), today reported financial results for the quarter ended June 30, 2008,...
PALATIN TECHNOLOGIES REPORTS SECOND QUARTER RESULTS
PRINCETON, NJ August 14, 2008- Palatin Technologies Inc (AMEX:PTN) today announced results for its second quarter ended December 31, 2001. Palatin also announced plans to hold a teleconference on Wednesday, February...
IGI Laboratories, Inc. Announces Second Quarter Results
BUENA, NJ August 14, 2008 - IGI Laboratories, Inc. (AMEX: IG) a premier provider of topical formulation development, analytical, manufacturing and packaging services announces second quarter 2008 results.
MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results
GERMANTOWN, Md., August 14, 2008 -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced financial and...
Nephros Reports Second Quarter 2008 Financial Results
NEW YORK, NY--August 14, 2008 - Nephros, Inc. (AMEX: NEP) announced today financial results for the three and six month periods ended June 30, 2008.
MINRAD Reports Results for Second Quarter 2008
August 14, 2008 -- MINRAD International, Inc. (Amex: BUF - News), an interventional pain management company, today reported revenue of $4.2 million for the second quarter of 2008, down 4 % compared to $4.3 million of...
Syneron Reports Record Second Quarter 2008 Revenues of $38.2 Million and Net Profit of $11.0 Million
YOKNEAM, ISRAEL --August/14/2008 -- Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, today announced its financial results...
Notes to the Interim Consolidated Financial Statements for the Period from January 1 to June 30, 2008
August 14,2008-The consolidated financial statements of STRATEC AG as of December 31, 2007 were compiled in accordance with the International Financial Reporting Standards (IFRS) as adopted by the EU valid at the...
Response Biomedical Corporation Announces Second Quarter Results
VANCOUVER, Aug. 14, 2008- Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) reported that it recorded total revenues of $997,515 and a net loss of $3,740,494 or ($0.03) per share for the three month period ended...
Vermillion Announces Second Quarter 2008 Financial Results and Business Progress
FREMONT, Calif., Aug. 14, 2008 -- Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, today announced financial results for the second quarter ended June 30, 2008, and provided an update on recent...
Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
SAN FRANCISCO, August 14, 2008 -- Nile Therapeutics, Inc. (Nasdaq: NLTX), today announced financial results for the three and six months ended June 30, 2008.
NeoPharm, Inc. Announces Second Quarter 2008 Financial Results
LAKE BLUFF, Ill -- August 14, 2008--NeoPharm, Inc. (NASDAQ: NEOL), today announced its second quarter 2008 financial results.
Nanosphere Announces Second Quarter 2008 Results
NORTHBROOK, Ill., August 14, 2008 -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today reported financial results for the second quarter...
Lipid Sciences, Inc. Reports Financial Results for the Second Quarter 2008
PLEASANTON, CA, August 14, 2008 -- Lipid Sciences, Inc. (NASDAQ: LIPD) today reported financial results for the second quarter of 2008. For the three months ending June 30, 2008, the Company reported a net loss of $2.0...
A.P. Pharma Reports Results for the Second Quarter 2008
REDWOOD CITY, Calif.--Aug. 14, 2008--A.P. Pharma, Inc. (NASDAQ: APPA), a specialty pharmaceutical company, today reported financial results for its second quarter ended June 30, 2008.
ART Announces Second Quarter 2008 Financial Results
Montreal, Canada, August 14, 2008 - ART Advanced Research Technologies Inc. (ART) (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical...
Jerini AG Reports Financial Results for First Half 2008
Berlin, August 14, 2008 - Jerini AG (FSE:JI4) reported financial results for the first six months ended June 30, 2008. Under International Financial Reporting Standards (IFRS), total revenues for this period decreased...
Adaltis Announces Second Quarter Financial Results
MONTREAL, QUEBEC--(Aug. 14, 2008) - Adaltis Inc. (TSX:ADS), an international in vitro diagnostic (IVD) company, today reported its second quarter 2008 financial results.
ViRexx Announces 2008 Second Quarter Results
EDMONTON, ALBERTA--( Aug. 14, 2008) - ViRexx Medical Corp. (TSX:VIR) (AMEX:REX), company focused on developing innovative-targeted therapeutic products that offer better quality of life and a renewed hope for living....
Ad-hoc Release Interim Report 200814.08.2008
August 14, 2008--CyBio AG, Jena, (German Stock Exchange: General Standard, ISIN number DE0005412308) generated consolidated turnover of EUR 7.7 million in the first half of 2008 (previous year: EUR 9.1 million)....
Dragon Pharma Reports 2008 Record Second Quarter Financial Results - Earning Per Share of $0.07 for the first half of 2008
Vancouver, Canada - August 14, 2008 - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced its financial results...
Revenue and profit in line with expectations
JENA/Germany, August 14, 2008--Medical technology provider Carl Zeiss Meditec, which is listed on the TecDAX of the German stock exchange (ISIN DE0005313704), generated consolidated revenue of EUR 446.6 million in the...
Cardiogenesis Reports Second Quarter 2008 Results
IRVINE, Calif., Aug. 14 -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products used in the treatment of patients suffering from severe angina, today reported financial results for its...
RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2008
WORCESTER, Mass.----Aug. 14, 2008--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi),...
Agilent Technologies Reports Third Quarter 2008 Results
SANTA CLARA, Calif., Aug. 14, 2008 --Agilent Technologies Inc. (NYSE: A) today reported orders of $1.39 billion for the third fiscal quarter ended July 31, 2008, 6 percent above one year ago. Revenues during the quarter...
Advanced Life Sciences Announces Second Quarter 2008 Financial Results
CHICAGO, Aug. 14 -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection,...
Revenue and profit in line with expectations
JENA/Germany, August 14, 2008--Medical technology provider Carl Zeiss Meditec, which is listed on the TecDAX of the German stock exchange (ISIN DE0005313704), generated consolidated revenue of EUR 446.6 million in the...
PROMETIC REPORTS BUSINESS HIGHLIGHTS AND SECOND QUARTER FINANCIAL RESULTS
MONTREAL, QUEBEC, CANADA - August 14, 2008 - ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") today reported business highlights and financial results for the second quarter of 2008. All amounts are in Canadian...
ELRON ELECTRONIC INDUSTRIES ANNOUNCES SECOND QUARTER 2008 RESULTS
Tel Aviv, Israel, August 14, 2008 - Elron Electronic Industries Ltd. (Nasdaq: ELRN) (TASE: ELRN) ("Elron" or the "Company") today reported financial results for the second quarter and first half of 2008.
Memory Pharmaceuticals Reports Second Quarter 2008 Financial Results
MONTVALE, N.J., August 13, 2008 -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today reported its financial results for the second quarter ended June 30, 2008.
CombiMatrix Corporation Reports Second Quarter 2008 Financial Results
MUKILTEO, Wash., Aug 13, 2008-- CombiMatrix Corporation (Nasdaq:CBMX) today reported its financial results for the three and six months ended June 30, 2008. Key highlights for the second quarter and through the date of...
Nymox Reports Second Quarter 2008 Financial Results
HASBROUCK HEIGHTS, NJ (August 13, 2008) Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today its financial results for the second quarter of 2008. Nymox reported a net loss of $1,138,139, or $0.04 per share...
Late-Stage Cardiovascular Programs Expected to Yield Significant Milestones Over the Coming Quarters
FREMONT, Calif., Aug 13, 2008 -- ARYx Therapeutics, Inc. (NASDAQ:ARYX) today reported results of operations and provided an update on its products for the second quarter ended June 30, 2008.
BOVIE MEDICAL CORPORATION ANNOUNCES SECOND QUARTER AND SIX MONTH FINANCIAL RESULTS; SECURES $5 MILLION LINE OF CREDIT COMMITMENT FROM RBC CENTURA BANK
Melville, New York, August 13, 2008 - Bovie Medical Corporation (the "Company") (Amex: BVX), a manufacturer and marketer of electrosurgical products, today announced second quarter and six month results for the period...
Inflazyme Pharmaceuticals Ltd. (IZP.TO) Announces Financial Results for the First Quarter Ended June 30, 2008
VANCOUVER, BRITISH COLUMBIA--(August 13, 2008) - Inflazyme Pharmaceuticals Ltd. (NEX: IZP.H) today reported its financial results for the first quarter ended June 30, 2008.
Abraxis BioScience, Inc. Reports Financial Results for the Second Quarter of 2008
LOS ANGELES--August 13, 2008--Abraxis BioScience, Inc. (NASDAQ: ABII), a fully integrated biotechnology company, today reported unaudited financial results for the second quarter ended June 30, 2008.
Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results
HOPKINTON, Mass., Aug 13, 2008 -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) today reports operational and financial results for the quarter ended June 30, 2008 and provides further information for fiscal year 2008.
Avalon Pharmaceuticals Reports Second Quarter 2008 Results
GERMANTOWN, Md.--Aug. 13, 2008--Avalon Pharmaceuticals, Inc. (Nasdaq:AVRX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer therapeutics, today announced financial and...
CORCEPT THERAPEUTICS ANNOUNCES SECOND QUARTER 2008 RESULTS
MENLO PARK, Calif., (August 13, 2008) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today reported financial results for the second quarter ended June 30, 2008.
Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results
BEIJING, Aug. 13, 2008 -- Sinovac Biotech Ltd. (Amex: SVA - News), a leading developer and provider of vaccines in China, today announced the Company's financial results for the six and three-month periods ended June...
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us